Possible New Adjuvant for Conjugate Vaccines Identified
Researchers find how bacteriophage derived nanoparticles could be used in vaccines against emerging antibiotic-resistant microorganisms.
Science
Read Full News
New Cancer Treatments Could Come from Understanding Diabetes
Scientists found new research avenues for cancer treatments by applying the changes seen in T cells of patients with type 1 diabetes.
Researchers Identify the First MHC II Peptide Binding Motifs in Dogs
New findings in The Journal of Immunology establish the first allele-specific peptide binding motif framework for canine MHC class II.
T cell Responses to mRNA COVID-19 Vaccines in IBD Patients Not Different from Healthy Individuals
Researchers investigate how T cell responses in IBD patients may differ from those of healthy individuals after mRNA vaccines.
Leaky Gut Might Make Food Allergies Worse
A “leaky gut” might increase the severity of food allergies, according to new research conducted in mice.
Influenza B Induces an Earlier, More Robust Immune Response than Influenza A
New research shows protective immunity is generated more rapidly in response to influenza B virus than Influenza A virus.
Susumu Tonegawa, Nobel Laureate and Distinguished Fellow of AAI, Dies at 86
Susumu Tonegawa, PhD, who won the 1987 Nobel Prize in Physiology or Medicine for “his discovery of the genetic principle…
Biomarkers Could Help Identify ICU Patients at Risk of Chronic Critical Illness
New research could lead to simple blood tests that identify which ICU patients are at increased risk of illness after traumatic injury.
The Journal of Immunology Increases Impact Factor
The Journal of Immunology (The JI) is pleased to announce that its 2025 Impact Factor has increased to 4.0, an…
CD7 Identified as a Potential Checkpoint to Limit T Cell Exhaustion
CD7 acts as a previously unrecognized driver of T cell exhaustion that could enhance cancer immunotherapy.